Immunohistochemical staining for Ki67, which is a known marker of active proliferation in cancer cells including glioma cells, also confirmed a significantly reduced progressive potential of C6 cells in tumor sections from treated rats (TMZ, RSV and TMZ + RSV) as compared to vehicle-treated rats (Control). This evidence concerns the gene MKI67 and glioma.